Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset
Clinical trial NCT04015713 · UNKNOWN
Trial details
- NCT number
- NCT04015713
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-21
- Primary completion
- 2021-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.